{
    "clinical_study": {
        "@rank": "157988", 
        "arm_group": [
            {
                "arm_group_label": "Placebo (maltodextrin)", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Maltodextrin"
            }, 
            {
                "arm_group_label": "Multi-Nutrient Blend", 
                "arm_group_type": "Active Comparator", 
                "description": "Blend of vitamins, minerals, and amino acids, given twice daily"
            }
        ], 
        "brief_summary": {
            "textblock": "Rotator Injury:\n\n        -  Strength/range of Motion\n\n        -  ASES, VAS"
        }, 
        "brief_title": "Nutritional Supplementation Effects on Rehabilitation Outcomes in Rotator Cuff Pathology", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Rotator Cuff/Shoulder Structure and Function", 
        "detailed_description": {
            "textblock": "The addition of a nutritional therapy to a standardized physical therapy program, may\n      expedite recovery from shoulder injury. An attractive feature of this approach is the\n      development of an efficacious adjunct therapy that is economically superior to traditional\n      therapy modalities and logistically feasible."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Between 18-65 years old\n\n          -  Diagnosed with rotator cuff injury that will not be treated surgically\n\n        Exclusion Criteria:\n\n          -  Have received a previous injection therapy (platelet-rich plasma or corticosteroid\n             injection) within previous 6 months\n\n          -  Have used the following supplements in the previous 2 weeks: Vitamin C or D, or\n             protein supplements\n\n          -  Have poorly controlled type I or type II diabetes (HgB A1C > 9.5%) or renal\n             insufficiency (GFR < 60 ml/min).\n\n          -  Have an inability to participate in rehabilitation exercises.\n\n          -  Are diagnosed with arthritis, rheumatoid arthritis, or any other autoimmune or\n             rheumatologic disease\n\n          -  Have musculoskeletal pathology in a neighboring joint or structure\n\n          -  Have an allergy to any component of the nutritional supplement\n\n          -  Are consuming warfarin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "56", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01798693", 
            "org_study_id": "ORB-12-2374"
        }, 
        "intervention": [
            {
                "arm_group_label": "Placebo (maltodextrin)", 
                "intervention_name": "Placebo (maltodextrin)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Multi-Nutrient Blend", 
                "intervention_name": "Multi-nutrient Blend", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Shoulder", 
            "Supplement", 
            "Amino Acids", 
            "Collagen", 
            "Standard of Care"
        ], 
        "lastchanged_date": "February 27, 2014", 
        "location": {
            "contact": {
                "last_name": "Smith-Ryan, PhD", 
                "phone": "919-962-2574"
            }, 
            "facility": {
                "address": {
                    "city": "Chapel Hill", 
                    "country": "United States", 
                    "state": "North Carolina"
                }, 
                "name": "UNC Orthopedics and Exercise and Sport Medicine"
            }, 
            "investigator": [
                {
                    "last_name": "D Berkoff, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Smith-Ryan, PhD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "last_name": "K Lamb", 
            "phone": "919-966-9066"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "University of North Carolina: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in shoulder function, pain, strength and range of motion", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline to four, six, and twelve weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01798693"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of North Carolina, Chapel Hill", 
            "investigator_full_name": "Abbie Smith-Ryan, PhD", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of North Carolina, Chapel Hill", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of North Carolina, Chapel Hill", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}